ArticlePloS one2025
Design optimization of high-sensitivity PCF-SPR biosensor using machine learning and explainable AI.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- ANN-PSO Hybrid ML-Optimization of a Hollow-Disk Resonator-Based Photonic Crystal Optical Sensor for HeLa Cell Tumor Detection.Sensors (Basel, Switzerland) · 2026Article
- Recent Progress in Artificial Intelligence in Biosensor Development: From Bioprobe Design to Fabrication and Signal Analysis.Biosensors · 2026Review
- Integration of computational optics and machine learning for optimized SPR-based carcinoembryonic antigen detection.Biomedical optics express · 2026Article
- Research Progress on Nanomaterials in SPR Sensors.Nanomaterials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photonic crystal fiber based surface plasmon resonance (PCF-SPR) biosensors are sophisticated optical sensing platforms that enable precise detection of minute refractive index (RI) variations for various applications. This study introduces a highly sensitive, low-loss, and simply designed PCF-SPR biosensor for label-free analyte detection, operating across a broad RI range of 1.31 to 1.42. In addition to conventional methods, machine learning (ML) regression techniques were integrated to predict key optical properties, while explainable AI (XAI) methods, particularly Shapley Additive exPlanations (SHAP), were used to analyze model outputs and identify the most influential design parameters. This hybrid approach significantly accelerates sensor optimization, reduces computational costs, and improves design efficiency compared to conventional methods. The proposed biosensor achieves impressive performance metrics, including a maximum wavelength sensitivity of 125,000 nm/RIU, amplitude sensitivity of -1422.34 RIU ⁻ ¹, resolution of 8 × 10 ⁻ ⁷ RIU, and a figure of merit (FOM) of 2112.15. ML models demonstrated high predictive accuracy for effective index, confinement loss, and amplitude sensitivity. SHAP analysis revealed that wavelength, analyte refractive index, gold thickness, and pitch are the most critical factors influencing sensor performance. The combination of a simple yet efficient design and advanced ML-driven optimization makes this biosensor a promising candidate for high-precision medical diagnostics, particularly cancer cell detection, and chemical sensing applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.